| Literature DB >> 29199401 |
Antonio L Faltado1, Anna Angelica Macalalad-Josue2, Ralph Jason S Li2, John Paul M Quisumbing2, Marc Gregory Y Yu2, Cecilia A Jimeno2.
Abstract
BACKGROUND: Determining risk factors for diabetes insipidus (DI) after pituitary surgery is important in improving patient care. Our objective is to determine the factors associated with DI after pituitary surgery.Entities:
Keywords: Diabetes insipidus; Neuroendocrinology; Neurosurgery; Postoperative complications; Vasopressins
Year: 2017 PMID: 29199401 PMCID: PMC5744728 DOI: 10.3803/EnM.2017.32.4.426
Source DB: PubMed Journal: Endocrinol Metab (Seoul) ISSN: 2093-596X
Demographic Data and Clinical Characteristics of Patients
| Characteristic | No DI ( | DI ( | Overall | |
|---|---|---|---|---|
| Age, yr | 46±14.1 | 38.6±16.4 | 44±15.1 | <0.001 |
| Sex | 0.460 | |||
| Female | 92 (55.4) | 32 (50.0) | 124 (53.9) | |
| Male | 74 (44.6) | 32 (50.0) | 106 (46.1) | |
| Mass size, cm | 3.3±1.1 | 3.4±1.2 | 3.3±1.1 | 0.135 |
| <1 | 6 (4.2) | 0 | 6 (3.1) | |
| ≥1 | 138 (95.8) | 52 (100.0) | 190 (96.9) | |
| Histopathology | 0.003 | |||
| Pituitary adenoma | 139 (84.2) | 50 (78.1) | 189 (82.2) | |
| Meningioma | 18 (10.9) | 1 (1.6) | 19 (8.3) | |
| Craniopharyngioma | 6 (3.6) | 13 (20.3) | 19 (8.3) | |
| Adenocarcinoma | 1 (0.6) | 0 | 1 (0.4) | |
| Glioma | 1 (0.6) | 0 | 1 (0.4) | |
| No data | 1 (0.6) | 0 | 1 (0.4) | |
| Pituitary adenoma functionality | 0.770 | |||
| Nonfunctioning | 113 (81.3) | 42 (84.0) | 155 (82.0) | |
| TSHoma | 1 (0.7) | 0 | 1 (0.5) | |
| Prolactinoma | 12 (8.6) | 4 (8.0) | 16 (8.5) | |
| GH-secreting | 6 (4.3) | 1 (2.0) | 7 (3.7) | |
| Cushing's disease | 5 (3.6) | 0 | 5 (2.7) | |
| GH and prolactin secreting | 0 | 1 (2.0) | 1 (0.5) | |
| No data | 2 (1.4) | 2 (4.0) | 4 (2.1) | |
| Type of surgery | 0.007 | |||
| Nasal approach | 96 (57.8) | 30 (46.9) | 126 (54.8) | |
| Labial approach | 36 (21.7) | 8 (12.5) | 44 (19.1) | |
| Craniotomy | 32 (19.3) | 25 (39.1) | 57 (24.8) | |
| Craniectomy | 0 | 1 (1.6) | 1 (0.4) | |
| Biopsy | 2 (1.2) | 0 | 2 (0.9) | |
| Status of surgery | 0.130 | |||
| Initial (primary) | 148 (90.2) | 53 (82.8) | 201 (88.2) | |
| Repeat | 16 (9.8) | 11 (17.2) | 27 (11.8) | |
| Surgeon | 0.110 | |||
| Consultant | 117 (70.5) | 38 (59.4) | 155 (67.4) | |
| Resident | 49 (29.5) | 26 (40.6) | 75 (32.6) | |
| Other postoperative complications | 0.530 | |||
| None | 151 (91.0) | 57 (89.0) | 208 (90.4) | |
| Death | 1 (0.6) | 0 | 1 (0.4) | |
| Hemorrhage | 4 (2.4) | 2 (3.1) | 6 (2.6) | |
| Infection | 4 (2.4) | 4 (6.3) | 8 (3.5) | |
| CSF leak | 3 (1.8) | 0 | 3 (1.3) | |
| Hydrocephalus | 2 (1.2) | 0 | 2 (0.9) | |
| Pneumocephalus | 1 (0.6) | 1 (1.6) | 2 (0.9) |
Values are expressed as mean±SD or number (%).
DI, diabetes insipidus; TSHoma, thyroid stimulating hormone secreting adenoma; GH, growth hormone; CSF, cerebrospinal fluid.
Laboratory Characteristics of Patients with and without Postoperative Diabetes Insipidus
| Characteristic | No DI ( | DI ( | 95% CI | |
|---|---|---|---|---|
| Preoperative serum Na, mmol/L | 139.2 (5.0)a | 139.5 (4.0) | 0.772 | 138.6–139.7 |
| Postoperative serum Na, mmol/L | 141.0 (4.0) | 144.9 (6.5) | <0.001 | 141.7–143.0 |
| Preoperative USG | 1.015 (0.01) | 1.015 (0.015) | 0.890 | 1.015–1.017 |
| Postoperative USG | 1.016 (0.014) | 1.005 (0.01) | <0.001 | 1.013–1.020 |
| Percent change in serum Na, % | 1.40 (4.32) | 3.60 (4.70) | <0.001 | 1.84–2.97 |
| Absolute change in serum Na, mmol/L | 2 (6.0) | 5 (6.5) | <0.001 | 2.48–4.01 |
| Percent change in USG, % | 0.2 (1.76) | −0.5 (1.07) | <0.001 | 0.14–1.79 |
| Absolute change in USG | 0.002 (0.017) | −0.005 (0.011) | <0.001 | −0.003 to 0.005 |
Values are expressed as median (interquartile range). Median (interquartile range) was used for non-normally distributed data.
DI, diabetes insipidus; CI, confidence interval; Na, sodium; USG, urine specific gravity.
Univariate Analysis
| Variable | OR | 95% CI | |
|---|---|---|---|
| Age, mean | 0.97 | 0.95–0.99 | 0.001 |
| Female sex | 1.24 | 0.70–2.22 | 0.460 |
| Mass size, cm | 1.00 | 0.99–1.00 | 0.867 |
| Mass type, microadenoma | 1.00 | 0.99–1.01 | 0.291 |
| Histopathology | |||
| Meningioma | 0.15 | 0.02–1.19 | 0.073 |
| Craniopharyngioma | 6.00 | 2.17–16.70 | 0.001 |
| Pituitary adenoma functionality | |||
| Prolactinoma | 0.90 | 0.27–2.94 | 0.857 |
| GH-secreting | 0.45 | 0.05–3.83 | 0.464 |
| Type of surgery | |||
| Labial approach | 0.71 | 0.30–1.70 | 0.442 |
| Craniotomy | 2.50 | 1.29–4.86 | 0.007 |
| Status of surgery | |||
| Repeat | 0.97 | 0.87–1.08 | 0.555 |
| Surgeon | |||
| Resident | 1.60 | 0.90–2.98 | 0.109 |
| Other postoperative complications | |||
| Hemorrhage | 1.32 | 0.24–7.43 | 0.749 |
| Infection | 2.65 | 0.64–10.9 | 0.178 |
| Pneumocephalus | 2.65 | 0.16–43.07 | 0.493 |
| Preoperative serum Na | 0.99 | 0.99–1.00 | 0.350 |
| Postoperative serum Na | 0.99 | 0.99–1.00 | 0.350 |
| Preoperative USG | 0.99 | 0.99–1.00 | 0.100 |
| Postoperative USG | 0.99 | 0.99–0.99 | 0.002 |
| Percent change in serum Na | 1.22 | 1.11–1.35 | <0.001 |
| Absolute change in serum Na | 1.17 | 1.09–1.26 | <0.001 |
| Percent change in USG | 0.65 | 0.48–0.87 | 0.004 |
| Absolute change in USG | 3.10e−19a | 1.22e−31–7.92e−7a | 0.003 |
OR, odds ratio; CI, confidence interval; GH, growth hormone; Na, sodium; USG, urine specific gravity.
aThe ‘e’ values in exponential form (1.22×10−31).
Multivariate Logistic Regression Analysis
| Variable | OR | 95% CI | |
|---|---|---|---|
| Percent change in serum Na | 1.39 | 1.15–1.69 | 0.001 |
| Percent change in USG | 0.53 | 0.33–0.87 | 0.012 |
| Preoperative serum Na | 1.19 | 1.02–1.40 | 0.026 |
| Preoperative USG | 2.84e−27a | 4.54e−56–177.68a | 0.071 |
| Histopathology | |||
| Meningioma | 0.05 | 0.004–0.70 | 0.025 |
| Craniopharyngioma | 0.50 | 0.09–2.66 | 0.415 |
| Type of surgery | |||
| Labial approach | 0.64 | 0.20–1.99 | 0.437 |
| Craniotomy | 5.48 | 1.60–18.80 | 0.007 |
OR, odds ratio; CI, confidence interval; Na, sodium; USG; urine specific gravity.
aThe ‘e’ values in exponential form (2.84×10-27).
Fig. 1Receiver operator characteristic (ROC) curves of various laboratory parameters. (A) Preoperative sodium. (B) Preoperative urine specific gravity. (C) Percent change in sodium. (D) Percent change in urine specific gravity.
Fig. 2Receiver operator characteristic (ROC) curve of the predictive model.